Variant report
Variant | esv1792427 |
---|---|
Chromosome Location | chr5:135744555-135755386 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs111758787 | chr5:135744589-135744590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551855545 | chr5:135744608-135744609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566865362 | chr5:135744614-135744615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188597490 | chr5:135744628-135744629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549089710 | chr5:135744643-135744644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146496048 | chr5:135744647-135744648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376572829 | chr5:135744654-135744655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112555134 | chr5:135744659-135744660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371200922 | chr5:135744688-135744689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141297314 | chr5:135744697-135744698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145030212 | chr5:135744743-135744744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557800843 | chr5:135744795-135744796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192543914 | chr5:135744846-135744847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs151276906 | chr5:135744847-135744848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372826569 | chr5:135744859-135744860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74612232 | chr5:135744974-135744975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573725599 | chr5:135744997-135744998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184373223 | chr5:135745074-135745075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140428491 | chr5:135745082-135745083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150409294 | chr5:135745097-135745098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545292456 | chr5:135745267-135745268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs346629 | chr5:135745273-135745274 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs527772295 | chr5:135745285-135745286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549499035 | chr5:135745300-135745301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558995365 | chr5:135745350-135745351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138317459 | chr5:135745384-135745385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189654186 | chr5:135745424-135745425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550419771 | chr5:135745465-135745466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182072569 | chr5:135745515-135745516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539376575 | chr5:135745532-135745533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144135263 | chr5:135745578-135745579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566698327 | chr5:135745580-135745581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146749502 | chr5:135745591-135745592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566159782 | chr5:135745595-135745596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555440828 | chr5:135745616-135745617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372339226 | chr5:135745620-135745621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139289206 | chr5:135745665-135745666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143213307 | chr5:135745694-135745695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143917715 | chr5:135745729-135745730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17791023 | chr5:135745768-135745769 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs148223589 | chr5:135745784-135745785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531962987 | chr5:135745791-135745792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560512808 | chr5:135745802-135745803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572648104 | chr5:135745814-135745815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554968053 | chr5:135745840-135745841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545727292 | chr5:135745896-135745897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561057863 | chr5:135745907-135745908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141135441 | chr5:135745908-135745909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112178527 | chr5:135745921-135745922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564972626 | chr5:135745926-135745927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Myelofibrosis | 19240791 | CNVD |
Developmental delay | 19128483 | CNVD |
Leukoplakia | 24403051 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:135742200-135754400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:135745000-135745800 | Enhancers | HUVEC | blood vessel |
3 | chr5:135749200-135749400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr5:135749400-135750600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr5:135750600-135750800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr5:135750600-135750800 | Bivalent Enhancer | Aorta | Aorta |
7 | chr5:135750800-135754600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr5:135752000-135753000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr5:135753000-135754000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:135753400-135756800 | Enhancers | Fetal Kidney | kidney |
11 | chr5:135754000-135754200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr5:135754000-135756800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr5:135754200-135754600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr5:135754400-135754800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr5:135754400-135756200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr5:135754600-135755200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr5:135754600-135756000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
18 | chr5:135755200-135760400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |